Fatima Laraba-Djebari

Prof. Dr. Fatima Laraba-Djebari

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
DTDjamel Tahtat
Djamel Tahtat
MMMohamed Mahlous
Mohamed Mahlous
SBSamah Benamer
Samah Benamer
AKAssia Nacer Khodja
Assia Nacer Khodja
HOHabiba Oussedik-Oumehdi
Habiba Oussedik-Oumehdi
FLFatima Laraba-Djebari
Fatima Laraba-Djebari

1 August 2008 in Experimental and Toxicologic Pathology
Verified
Journal Article
Closed access
SASonia Adi-Bessalem
Sonia Adi-Bessalem
DHDjelila Hammoudi-Triki
Djelila Hammoudi-Triki
FLFatima Laraba-Djebari
Fatima Laraba-Djebari

1 April 2004 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
DHDjélila Hammoudi-Triki
Djélila Hammoudi-Triki
EFElisabeth Ferquel
Elisabeth Ferquel
ARAnnie Robbe-Vincent
Annie Robbe-Vincent
CBCassian Bon
Cassian Bon
VCValérie Choumet
Valérie Choumet
FLFatima Laraba-Djebari
Fatima Laraba-Djebari
An epidemiological and biological survey of scorpion envenomation was conducted in Algeria. Analysis of 182 medical files showed that 70% of the patients were stung by Androctonus australis. Most accidents occurred during the morning (40%) or the evening (30%). Two-thirds of the patients reached a hospital 1 hour after being stung. Their clinical symptoms classified 78% of them as Grade I (mild envenomation) and 17% of them as Grade II (moderate envenomation) on admission to hospital. No severe envenomation (Grade III) was reported. Most patients were treated with antivenom by the intramuscular route. Blood samples were collected before and after antivenom immunotherapy. A good correlation was observed between the grade of envenomation on admission and the blood venom concentrations measured by ELISA. The venom concentration decreased as function of the interval between the sting and blood collection (t1/2 = 2 h). Intramuscular injection of 10 ml of antivenom did not efficiently neutralize scorpion venom. Inflammation was followed by measuring IL6 concentration. IL6 peaked 1 h after scorpion envenomation. This study shows that optimization of the administration of antivenom is required to achieve clinical efficiency. In particular, intravenous injection of a larger dose of a more potent antivenom should be considered.


1 November 1995 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
FLFatima Laraba-Djebari
Fatima Laraba-Djebari
MMMarie‐France Martin‐Eauclaire
Marie‐France Martin‐Eauclaire
GMGérard Mauco
Gérard Mauco
Pascale MARCHOTPascale MARCHOT
Pascale MARCHOT
Afaâcytin, a proteinase with caseinolytic, arginine‐esterase and amidase activities, was purified from the venom of Cerastes cerastes (horned viper) in two steps by gel filtration through Sephadex G75, then HPLC on carboxymethyl‐cellulose. Afaâcytin has an isoelectric point of 6.25. and consists of two sub‐units, α and β, which have the same apparent molecular mass (40000) and are indistinguishable in the absence of reduction or/and deglycosylation. Subunit β is constituted of two disulfide‐linked polypeptidic chains, β and β′. The respective apparent molecular mass of the chains are 43000 (α), 35500 (β) and 10200 (β') as determined by SDS/PAGE under reducing conditions. Both chains α and β are N‐glycosylated. The two chains have the same N‐terminal sequence (20 residues) which is similar to those of other proteinases from snake venom. Susceptibility of afaâcytin to diisopropyl fluorophosphate and benzamidine indicates the presence of a serine and an aspartic (or glutamic) acid residues in the catalytic site. Ca2+ appears to be required for structural cohesion of the afaâcytin molecule. Afaâcytin exhibits αβ‐fibrinogenase and α‐fibrinase properties. It replaces missing factors VIII and IX in deficient plasmas, and activates purified human factor X into factor Xa. It releases serotonin from platelets and directly aggregates human (but not rabbit) blood platelets. Despite its thrombin‐like characteristics, however, afaâcytin is not inhibited by plasmatic thrombin inhibitors. The procoagulant properties of afaâcytin therefore have potential clinical applications.

1 December 1996 in International Journal of Peptide and Protein Research
Verified
Journal Article
Closed access
PDF file
HZH. Zerrouk
H. Zerrouk
FLFatima Laraba-Djebari
Fatima Laraba-Djebari
VFV. Fremont
V. Fremont
AMA. Meki
A. Meki
HDH. Darbon
H. Darbon
MMM.F. Martin‐Eauclaire
M.F. Martin‐Eauclaire